Drug Search Results
More Filters [+]

Bacampicillin

Alternative Names: bacampicillin, spectrobid
Latest Update: 2021-04-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PBP Antagonist,Cell Wall Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | India | Ireland | Italy | Korea | New Zealand | Pakistan | Peru | Portugal | Sweden | Taiwan | Turkey | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bacampicillin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title